German Research Foundation skeptical on cloning of human cells

NewsGuard 100/100 Score

According to a paper published in the journal Stem Cells, an American group has succeeded in inserting cell nuclei from human skin cells into human enucleated oocytes and to stimulate these new cells to undergo cell division in the laboratory.

This may constitute the first step on the way towards cloning human cells. Many issues relating to the method employed remain unclear at present.

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) already expressed its skepticism regarding the process of “therapeutic cloning” or “research cloning” when it released a statement on the issue of stem cell research in the autumn of 2006. Both for scientific reasons, and because this method calls for a large number of eggs from young donors, the DFG has given clear priority to research into reprogramming methods. Developments since late 2006 have confirmed the DFG's stance. Research done by American and Japanese groups, for example, has shown that it is possible to convert human skin cells back into cells similar to stem cells by treating them with reprogramming factors.

The DFG is also very critical of recent findings in the field of “research cloning in the human system”. Experiments of this kind are prohibited in Germany, as is importing cloned cell lines. The DFG has no intention of changing its current position.

Rather, the DFG continues to support research into the reprogramming of adult and embryonic stem cells.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies